Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non‐human primate studies and clinical trials.
Saved in:
| Title: | Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non‐human primate studies and clinical trials. |
|---|---|
| Authors: | Nicholls, Stephen J.1 (AUTHOR), Nelson, Adam J.1 (AUTHOR), Kastelein, John J. P.2 (AUTHOR), Ditmarsch, Marc2 (AUTHOR) marc.ditmarsch@newamsterdampharma.com, Hsieh, Andrew2 (AUTHOR), Johnson, Judith2 (AUTHOR), Curcio, Danielle2 (AUTHOR), Kling, Douglas2 (AUTHOR), Kirkpatrick, Carol F.3 (AUTHOR), Davidson, Michael H.2 (AUTHOR) |
| Source: | Pharmacology Research & Perspectives. Dec2024, Vol. 12 Issue 6, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20521707 |
|---|---|
| DOI: | 10.1002/prp2.70010 |
